$14.41
0.271.91%
At close: -
$13.10
-1.31-9.09%
After Hours: Dec 23, 8:17 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Contineum Therapeutics in recent months.
Browse guidance and forecast on all stocks.